Ovarian Cancer Clinical Trials 2023

Ovarian Cancer Clinical Trials 2023

Ovarian Cancer research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in ovarian cancer clinical trials today.

Ovarian Cancer Clinical Trials

Here are the 6 most popular medical studies for ovarian cancer

Popular filter options for ovarian cancer trials

Ovarian Tumors Clinical Trials

View 85 Ovarian Tumors medical studies.

Endometrioid Adenocarcinoma Clinical Trials

View 79 Endometrioid Adenocarcinoma medical studies.

Metastatic Ovarian Cancer Clinical Trials

View 91 metastatic ovarian cancer medical studies.

PD-L1 Positive Clinical Trials

View 11 PD-L1 positive medical studies.

PD-1 Positive Clinical Trials

View 10 PD-1 positive medical studies.

Phase 3 Ovarian Cancer Clinical Trials

View 91 phase 3 ovarian cancer medical studies.

Ovarian Cancer Clinical Trials With No Placebo

View 91 ovarian cancer medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to ovarian cancer

What are the top hospitals conducting ovarian cancer research?

When it comes to cutting-edge clinical trials in the battle against ovarian cancer, several top hospitals are making significant strides. In Houston, M D Anderson Cancer Center stands out with 11 ongoing trials dedicated to ovarian cancer and an impressive record of 49 completed studies since their first trial in 2003. Massachusetts General Hospital in Boston is also at the forefront, currently conducting 10 active ovarian cancer trials and having amassed a total of 56 trials over time since they began investigating this disease back in 2002.

Meanwhile, Memorial Sloan Kettering Cancer Center in New York has made substantial contributions as well. They have six ongoing ovarian cancer trials and have conducted a noteworthy total of 60 trials since recording their inaugural study in 1994. On the West Coast, Kaiser Permanente Los Angeles Medical Center takes part with six active ovarian cancer trials while they've accumulated eleven previous investigations; their commitment started relatively recently with their first recorded trial taking place just sixteen years agoin2005.

Additionally adding itself to this list is Mayo Clinic located at Arizona's Scottsdale where there are aroundsixongoing clinical tests concerningovarian carcinoma while fifteencompleted experiments priorly wereconducted by them within thatfieldw

Which are the best cities for ovarian cancer clinical trials?

Los Angeles, California; New York, New York; and Boston, Massachusetts are notable cities for ovarian cancer, Massachusetes, California; New York, New York; and Boston, Massachusetts are notable cities for ovarian cancer clinical trials. Los Angeles has 37 active trials investigating treatments like Paclitaxel, Bevacizumab, and Cisplatin. In New York City, there are 36 ongoing studies focused on BMS-986340, Paclitaxel, LY3537982 among others. Meanwhile in Boston researchers are conducting 36 active trials exploring Olaparib 300mg tablets, Dendritic Cell/Tumor Fusion Vaccine and Bevacizumab as potential treatment options. These cities offer individuals with ovarian cancer access to cutting-edge clinical trials and potential breakthroughs in care.

Which are the top treatments for ovarian cancer being explored in clinical trials?

Clinical trials are at the forefront of advancing treatments for ovarian cancer, with several promising options currently under exploration. Paclitaxel, a well-established drug since 1999, is being tested in five active trials and has participated in an impressive 155 all-time ovarian cancer5 all-time ovarian cancer trials. Another contender making waves is niraparib, introduced in 2015 and currently involved in five ongoing trials along with a track record of 45 all-time studies for ovarian cancer. Additionally, bevacizumab shows promise with its involvement in five active clinical trials and participation in 80 all-time ovarian cancer trials since its introduction back in 2003. Lastly, carboplatin remains relevant after two decades since first listed; it is currently participating in three active clinical trials while having been included across an extensive history of 141 all-time ovarian cancer studies. These innovative developments hold great potential to improve outcomes for individuals battling this complex disease.

What are the most recent clinical trials for ovarian cancer?

Exciting advancements in ovarian cancer research offer hope for improved treatment options. Recent clinical trials have explored various approaches to tackle this disease. One such trial, Part II Multiple Participant Cohort RO7515629 Dose Escalation, combines Phase 1 and Phase 2 studies to investigate the effectiveness of a new therapy for ovarian cancer patients. Another study focuses on AB-1015, a potential treatment that has entered Phase 1 testing with encouraging results so far. Additionally, SGN-PDL1V is being evaluated in a Phase 1 trial as a targeted therapy specifically designed for ovarian cancer patients. Paclitaxel is also under investigation in a Phase 2 study aiming to gain further insights into its efficacy against ovarian cancer. With these ongoing trials and their promising findings, there is renewed optimism surrounding the future of ovarian cancer treatments.

What ovarian cancer clinical trials were recently completed?

Several clinical trials for ovarian cancer have recently reached completion, demonstrating progress in the pursuit of improved treatments. Among them is a trial sponsored by Astellas Pharma Global Development, Inc., investigating ASP0739, which concluded in January 2022. Additionally, the Masonic Cancer Center at the University of Minnesotac Cancer Center at the University of Minnesota completed a trial evaluating Enoblituzumab in April 2021. Furthermore, Rucaparib was studied in a trial sponsored by pharmaand GmbH and finished its course in March 2021. These recent advancements signify the ongoing efforts to combat ovarian cancer and provide hope for patients facing this challenging disease.